Anastrozole Tablet
Product Images NDC 68071-3853

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 68071-3853). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3853 8)

Label for Anastrozole 1 mg tablets by NuCare Pharmaceuticals, Inc. The label shows a bottle containing 8 tablets. Tablets are described as round, white to off-white, debossed with 'AN' and '1' on one side. The label includes product number P2235008, the NDC 68071-3853-8, and storage instructions at controlled temperature 68-77°F. Manufacturer is Natco Pharma Limited, Visakhapatnam, India.*

FDA Label Image

Chemical Structure (Anastrozole 01)

Chemical structure diagram of the active ingredient Anastrozole, showing a benzene ring with attached nitrile groups and a triazole ring connected via an ethyl linker.*

FDA Label Image

Figure 1 (Anastrozole 02)

A Kaplan-Meier curve comparing disease-free survival in months between patients treated with anastrozole and tamoxifen. The y-axis shows the proportion alive and disease-free, ranging from 0 to 1. Below the graph, the number of patients at risk over time is listed for both treatments.*

FDA Label Image

Figure 2 (Anastrozole 03)

A Kaplan-Meier survival curve comparing disease-free survival over months for two randomized treatment groups: anastrozole (dashed line) and tamoxifen (solid line). The y-axis represents the proportion of patients alive and disease-free, and the x-axis shows months of follow-up. Below the graph, the number of patients at risk for each treatment group is displayed at multiple time points up to 90 months.*

FDA Label Image

Figure 3 (Anastrozole 04)

A Kaplan-Meier survival curve graph comparing the proportion event-free over time (months) between two treatments: Anastrozole (solid line) and Tamoxifen (dashed line). The x-axis represents time to event in months up to 120 months, and the y-axis shows the proportion event-free ranging from 0.5 to 1. Below the graph, the number of patients at risk is tabulated for each treatment group at multiple time points.*

FDA Label Image

Figure 4 (Anastrozole 05)

A Kaplan-Meier survival curve chart comparing the proportion of event-free patients over time in months between two randomized treatments: Anastrozole and Tamoxifen. The x-axis represents time to event in months, and the y-axis shows the proportion event-free. Below the chart, a table lists the number of patients at risk at different time points up to 120 months for each treatment.*

FDA Label Image

Figure 5 (Anastrozole 06)

A Kaplan-Meier survival curve chart showing the proportion of patients not progressing over time in months. The chart compares two randomized treatments, Anastrozole (solid line) and Tamoxifen (dashed line), with the Y-axis representing the proportion not progressing and the X-axis representing time to progression in months. Below the graph, the number of patients at risk is tabulated across various time points.*

FDA Label Image

Figure 6 (Anastrozole 07)

A Kaplan-Meier progression-free survival curve comparing the proportion of patients not progressing over time in months between Anastrozole and Tamoxifen randomized treatments. The x-axis represents time to progression in months, and the y-axis shows the proportion not progressing. The graph includes risk numbers below the time points.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.